GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development11,72115,32513,1148,425
Selling General and Administrative4,5266,1566,9656,855
Non Recurring----
Others----
Total Operating Expenses16,24721,48120,07915,280
Operating Income or Loss-16,247-21,481-20,079-15,280
Income from Continuing Operations
Total Other Income/Expenses Net124552-508
Earnings Before Interest and Taxes-16,247-21,481-20,079-15,280
Interest Expense-12-12-12-12
Income Before Tax-16,235-21,436-20,027-15,788
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-16,235-21,436-20,027-15,788
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-16,235-21,436-20,027-15,788
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-17,467-22,350-21,124-16,960